+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prefilled Syringe Fill Finish Manufacturing Market: Industry Trends and Global Forecasts - Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel Chambers, Type of Drug Molecule, Scale of Operation and Key Geographical Regions

  • PDF Icon

    Report

  • 267 Pages
  • December 2025
  • Region: Global
  • Roots Analysis
  • ID: 5025047
Description Jump to:
The global prefilled syringe fill finish manufacturing market valued at USD 931 million in the current year is anticipated to grow at a lucrative CAGR of 11.9% during the forecast period.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: GROWTH AND TRENDS

Fundamentally, a prefilled syringe is a single dose of medication, containing a pre-measured amount of injectable. It is used as a primary drug container for injectable drugs and vaccines. Some of the categories of drugs packaged in prefilled syringes include blood stimulants, erythropoietin products, interferons and therapeutic proteins. Over the past ten years, with the increase in development of parenteral drugs, the usage of prefilled syringes has tripled.

Notably, these prefilled syringes offer several advantages over traditional drug delivery systems (such as vials and syringes), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. As a result, prefilled syringes are preferably being used in the delivery of injectable drugs, especially in the treatment of chronic diseases (requiring repeated administration of the medications).

The numerous benefits offered by prefilled syringes, coupled with the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations. Moreover, owing to a number of operational challenges, such as the requirement of technical expertise associated with close monitoring and control of syringe fill volume, the market has witnessed a shift in trend towards outsourcing of the fill / finish operations for prefilled syringes. Additionally, the current demand for safer, easier to use administration technologies along with the industry’s efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringe fill finish manufacturing market in future.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: KEY INSIGHTS

The report delves into the current state of the global prefilled syringe fill finish manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:
  • Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.

  • The market landscape features the presence of well-established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.

  • Over 55% of the companies have the capabilities to offer fill / finish services for both small molecules and biologics; ~20% of the companies are offering these services for only biologics.
  • In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.
  • Several contract service providers (~60), including AMRI, Catalent Biologics, Pierre Fabrre and Sandoz offer fill / finish services at both clinical and commercial scale of operation.
  • Although most industry stakeholders are based in the developed regions, fill / finish operations in Asian countries, such as India, Taiwan and Bangladesh, are emerging.
  • Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
  • As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
  • An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
  • Around 70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
  • We expect drug developers to continue to outsource their fill / finish operations in the short to midterm, resulting in an annualized growth at the rate of over 11.9% within the contract services market.

  • In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.
  • With an increasing demand for prefilled syringes and focus on user-friendly systems, the market opportunity is projected to evolve at a rapid pace in the coming years.

Example Players in the Prefilled Syringe Fill Finish Manufacturing Market

  • Ajinomoto Bio-Pharma Services
  • AMRI
  • BioPharma Solutions
  • Emergent BioSolutions
  • Patheon (a Thermo Fisher Scientific Company)
  • Consort Medical
  • EVER Pharma
  • GlaxoSmithKline
  • IDT Biologika
  • Rentschler Biopharma
  • Siegfried
  • Vetter Pharma
  • Biocon
  • Intas Pharmaceuticals
  • Kemwell Biopharma
  • Square Pharmaceuticals.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: RESEARCH COVERAGE

  • Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the prefilled syringe fill finish manufacturing market, focusing on key market segments, including [A] type of therapeutic area, [B] type of syringe barrel material, [C] number of barrel chambers, [D] type of drug molecule, [E] scale of operation and [F] key geographical regions.
  • Market Landscape: A comprehensive evaluation of companies offering contract fill / finish services for prefilled syringes, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] scale of operation, [D] location of the headquarters, [E] location of fill / finish facilities, [F] type of drug molecule, [G] syringe barrel material, [H] syringe fill volume and additional services offered and [I] installed capacity.
  • Company Profiles: In-depth profiles of the players engaged in this domain, focusing on [A] overview of the company, [B] financial information (if available), [C] service portfolio, [D] fill / finish facilities and [E] recent developments and an informed future outlook.
  • Recent Developments: A comprehensive competitive analysis of recent developments pertaining to contract fill / finish services, based on various parameters, such as [A] year of development, [B] type of activity / development, [C] scale of operation of the project, [D] location of expanded facility, [E] type of drug molecule involved and [F] additional services offered.
  • Capacity Analysis: An in-depth analysis of contract fill / finish capacity of prefilled syringes, examining factors, such as [A] company size of manufacturer, [B] scale of operation, [C] location of headquarters and fill / finish facilities and [D] type of drug molecule.
  • Demand Analysis: A detailed analysis of the current and future demand for fill / finish of prefilled syringes, based on various parameters, such as [A] marketed drugs available, [B] target patient population, [C] dosing frequency, [D] dose strength, [E] geography, [F] type of drug molecule, [G] therapeutic area, [H] syringe barrel material and [I] number of barrel chambers.
  • Geographical Assessment of Demand and Supply: An insightful geographical analysis of demand and supply, based on several parameters, such as [A] number of prefilled syringe combination product developers, [B] number of prefilled syringe manufacturers, [C] number of prefilled syringe fill / finish service providers, [D] number of prefilled syringe fill / finish facilities, and [E] capacity and demand for prefilled syringes in that particular geographical region.
  • Likely Partner Analysis: A detailed analysis of the potential strategic partners for prefilled syringe fill / finish service providers, based on various parameters, such as [A] developer strength, [B] pipeline strength, [C] type of drug molecule, [D] target therapeutic area and [E] location of the headquarters of the company.
  • Case Study 1: A detailed discussion on the potential areas of growth, such as [A] growing injectable drugs pipeline, [B] increasing popularity of prefilled syringes, [C] rise in preference for outsourcing of fill / finish operations, [D] technological advancements in aseptic fill / finish processes and [E] growing opportunities in the Asia-Pacific region.
  • Case Study 2: Elaborate assessment of prefilled syringe manufacturers landscape, based on a number of relevant parameters, such as [A] syringe barrel material, [B] number of barrel chambers, [C] type of needle system, [D] barrel volume, [E] year of establishment and [F] location of the headquarters of manufacturers.

KEY QUESTIONS ANSWERED IN THIS REPORT

  • How many companies are currently engaged in this market?
  • Which are the leading companies in this market?
  • What factors are likely to influence the evolution of this market?
  • What is the current and future market size?
  • What is the CAGR of this market?
  • How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

  • The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
  • Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
  • The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

  • Complimentary PPT Insights Packs
  • Complimentary Excel Data Packs for all Analytical Modules in the Report
  • 15% Free Content Customization
  • Detailed Report Walkthrough Session with the Research Team
  • Free Updated report if the report is 6-12 months old or older

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.2.1. Research Assumptions
1.2.2. Project Methodology
1.2.3. Forecast Methodology
1.2.4. Robust Quality Control
1.2.5. Key Considerations
1.2.5.1. Demographics
1.2.5.2. Economic Factors
1.2.5.3. Government Regulations
1.2.5.4. Supply Chain
1.2.5.5. COVID Impact / Related Factors
1.2.5.6. Market Access
1.2.5.7. Healthcare Policies
1.2.5.8. Industry Consolidation
1.3 Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Introduction to Prefilled Syringes
3.2.1. Classification of Prefilled Syringes
3.2.2. Manufacturing of Prefilled Syringes
3.2.3. Advantages of Prefilled Syringes
3.2.3.1. Benefits to Healthcare Professionals and End Users
3.2.3.2. Benefits to Manufacturers
3.3. Fill / Finish Processing of Prefilled Syringes
3.3.1. Steps Involved in Fill / Finish Process
3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
3.3.3. Prefilled Syringe Filling Technologies
3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
3.6. Advantages of Outsourcing Fill / Finish Services
3.7. Risks Associated with Outsourcing of Fill / Finish Operations
3.8. Key Considerations While Selecting a Fill / Finish Service Provider
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Scale of Operation
4.2.4. Analysis by Location of Headquarters
4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
4.2.6. Analysis by Type of Drug Molecule
4.2.7. Analysis by Syringe Barrel Material
4.2.8. Analysis by Syringe Fill Volume
4.2.9. Analysis by Additional Services Offered
4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES
5.1. Chapter Overview
5.2. Ajinomoto Bio-Pharma Services
5.2.1. Company Overview
5.2.2. Recent Developments and Future Outlook
5.3. AMRI
5.3.1. Company Overview
5.3.2. Recent Developments and Future Outlook
5.4. BioPharma Solutions
5.4.1. Company Overview
5.4.2. Recent Developments and Future Outlook
5.5. Emergent BioSolutions
5.5.1. Company Overview
5.5.2. Recent Developments and Future Outlook
5.6. Patheon (a Thermo Fisher Scientific Company)
5.6.1. Company Overview
5.6.2. Recent Developments and Future Outlook
6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES
6.1. Chapter Overview
6.2. Consort Medical
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. EVER Pharma
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. GlaxoSmithKline
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6.5. IDT Biologika
6.5.1. Company Overview
6.5.2. Recent Developments and Future Outlook
6.6. Rentschler Biopharma
6.6.1. Company Overview
6.6.2. Recent Developments and Future Outlook
6.7. Siegfried
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Vetter Pharma
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Biocon
7.2.1. Company Overview
7.2.2. Recent Developments and Future Outlook
7.3. Intas Pharmaceuticals
7.3.1. Company Overview
7.3.2. Recent Developments and Future Outlook
7.4. Kemwell Biopharma
7.4.1. Company Overview
7.4.2. Recent Developments and Future Outlook
7.5. Square Pharmaceuticals
7.5.1. Company Overview
7.5.2. Recent Developments and Future Outlook
8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. List of Expansions
8.2.1. Analysis by Year of Expansion
8.2.2. Analysis by Type of Expansion
8.2.3. Analysis by Expanded Scale of Operation
8.2.4. Analysis by Location of Expansion Project
8.2.5. Analysis by Type of Drug Molecule Involved
8.2.6. Analysis by Additional Services Offered (Expansion Specific)
8.3. Partnership Models
8.4. List of Partnerships and Collaborations
8.4.1. Analysis by Year of Partnership
8.4.2. Analysis by Type of Partnership
8.4.3. Analysis by Scale of Operation (Deal Specific)
8.4.4. Analysis by Additional Services Offered (Deal Specific)
9. CAPACITY ANALYSIS
9.1. Chapter Overview
9.2. Assumptions and Methodology
9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
9.3.1. Analysis by Company Size
9.3.2. Analysis by Scale of Operation
9.3.3. Analysis by Location of Headquarters
9.3.4. Analysis by Location of Fill / Finish Facilities
9.3.5. Analysis by Type of Drug Molecule
9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
9.4.1. Analysis by Company Size (Manufacturer)
9.4.2. Analysis by Scale of Operation
9.4.3. Analysis by Location of Headquarters
9.4.4. Analysis by Location of Fill / Finish Facilities
9.4.5. Analysis by Type of Drug Molecule
10. DEMAND ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Methodology
10.3. Global Demand for Prefilled Syringes Fill / Finish Services
10.3.1. Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
10.3.1.1. Analysis by Geography
10.3.1.1.1. North America
10.3.1.1.2. Europe
10.3.1.1.3. Asia-Pacific
10.3.1.1.4. Latin America
10.3.1.1.5. Middle East and Africa
10.3.1.2. Analysis by Syringe Barrel Material
10.3.1.3. Analysis by Number of Barrel Chambers
10.3.1.4. Analysis by Type of Drug Molecule
10.3.1.5. Analysis by Therapeutic Area
10.3.1.6. Analysis by Specialty Syringes
10.3.2. Global Demand for Clinical Prefilled Syringes Fill / Finish Services
10.4. Demand and Supply Analysis
10.4.1. Demand and Supply Analysis (Scenario 1)
10.4.2. Demand and Supply Analysis (Scenario 2)
10.4.3. Demand and Supply Analysis (Scenario 3)
11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY
11.1. Chapter Overview
11.2. Assumptions and Key Parameters
11.3. Demand and Supply Assessment in North America
11.3.1. Key Geographies
11.3.1.1. US
11.4. Demand and Supply Assessment in Europe
11.4.1. Key Geographies
11.4.1.1. France
11.4.1.2. Germany
11.4.1.3. Italy
11.5. Demand and Supply Assessment in Asia-Pacific Region
11.5.1. Key Geographies
11.5.1.1. India
11.5.1.2. Japan
12. LIKELY PARTNER ANALYSIS
12.1. Chapter Overview
12.2. Methodology and Key Parameters
12.3. Likely Partner Analysis
12.3.1. Opportunities in North America
12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2. Opportunities in Europe
12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3. Opportunities in Asia-Pacific and Rest of the World
12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
13. MARKET SIZING AND OPPORTUNITY ANALYSIS
13.1. Chapter Overview
13.2. Forecast Methodology and Key Assumptions
13.3. Overall Prefilled Syringe Fill / Finish Services Market, Till 2035
13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, Till 2035
13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, Till 2035
13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, Till 2035
13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, Till 2035
14. FUTURE GROWTH OPPORTUNITIES
14.1. Chapter Overview
14.2. Growing Injectable Drugs Pipeline
14.3. Increase in Popularity of Prefilled Syringes
14.4. Rise in Preference for Outsourcing Fill / Finish Activities
14.5. Advances in Aseptic Fill / Finish Technologies
14.6. Growing Opportunities in the Asia-Pacific Region
15. CASE STUDY: PREFILLED SYRINGE MANUFACTURERS
15.1. Chapter Overview
15.2. Prefilled Syringes: List of Available / Under Development Devices
15.2.1. Analysis by Syringe Barrel Material
15.2.2. Analysis by Number of Barrel Chambers
15.2.3. Analysis by Type of Needle System
15.2.4. Analysis by Barrel Volume
15.3. Prefilled Syringes: List of Manufacturers
15.3.1. Analysis by Year of Establishment
15.3.2. Analysis by Location of Headquarters
16. CONCLUDING REMARKS
16.1. Chapter Overview
16.2. Key Takeaways
17. INTERVIEW TRANSCRIPTS
17.1. Chapter Overview
17.2. Company A
17.2.1. Company Snapshot
17.2.2. Interview Transcript: President and Cofounder
17.3. Company B
17.3.1. Company Snapshot
17.3.2. Interview Transcript: Chief Technical Officer
17.4. Company C
17.4.1. Company Snapshot
17.4.2. Interview Transcript: Chief Commercial Officer
17.5. Company D
17.5.1. Company Snapshot
17.5.2. Interview Transcript: Associate Director, Head of Process Sciences Formulation and Fill / Finish
17.6. Company E
17.6.1. Company Snapshot
17.6.2. Interview Transcript: Research Director and Head of Formulation Development
17.7. Company F
17.7.1. Company Snapshot
17.7.2. Interview Transcript: Design Director
18. APPENDIX 1: TABULATED DATA19. APPENDIX 2: LIST OF COMPANIES
LIST OF FIGURES
Figure 3.1 Prefilled Syringe Manufacturing: Common Processes
Figure 3.2 Prefilled Syringes: Fill / Finish Process
Figure 3.3 Risks and Challenges of Outsourcing Fill / Finish Operations
Figure 3.4 Key Considerations while Selecting a Fill / Finish Service Provider
Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Prefilled Syringe Fill / Finish Facilities
Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Type of Drug Molecule
Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
Figure 4.10 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
Figure 4.11 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation and Location of Fill / Finish Facilities
Figure 4.12 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
Figure 8.1 Expansions: Distribution by Year of Expansion, Since 2015
Figure 8.2 Expansions: Distribution by Type of Expansion
Figure 8.3 Expansions: Distribution by Expanded Scale of Operation
Figure 8.4 Expansions: Distribution by Location of Expansion Project
Figure 8.5 Expansions: Distribution by Type of Drug Molecule Involved
Figure 8.6 Expansions: Distribution by Additional Services Offered (Expansion Specific)
Figure 8.7 Partnerships and Collaborations: Cumulative Trend by Year, Since 2015
Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.9 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
Figure 8.10 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Company Size (Sample Data Set)
Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Units)
Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Liters)
Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
Figure 10.2 Global, Demand for Commercialized Prefilled Syringe Fill / Finish Services
Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of North America
Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Europe
Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Asia-Pacific
Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Latin America
Figure 10.7 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Middle East and Africa
Figure 10.8 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
Figure 10.9 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
Figure 10.10 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
Figure 10.11 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
Figure 10.12 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Specialty Syringes
Figure 10.13 Global, Demand for Clinical Prefilled Syringe Fill / Finish Services
Figure 10.14 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 1)
Figure 10.15 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 2)
Figure 10.16 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 3)
Figure 11.1 Demand and Supply Assessment: North America
Figure 11.2 Demand and Supply Assessment: US
Figure 11.3 Demand and Supply Assessment: Europe
Figure 11.4 Demand and Supply Assessment: France
Figure 11.5 Demand and Supply Assessment: Germany
Figure 11.6 Demand and Supply Assessment: Italy
Figure 11.7 Demand and Supply Assessment: Asia-Pacific Region
Figure 11.8 Demand and Supply Assessment: India
Figure 11.9 Demand and Supply Assessment: Japan
Figure 12.1 Likely Partner Analysis: Distribution by Company Size and Location of Headquarters
Figure 13.1 Overall Prefilled Syringe Fill / Finish Services Market, Till 2035 (USD Billion)
Figure 13.2 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation (USD Million)
Figure 13.3 Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location (USD Million)
Figure 13.4 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, North America (USD Million)
Figure 13.5 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Europe (USD Million)
Figure 13.6 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Asia-Pacific (USD Million)
Figure 13.7 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Latin America (USD Million)
Figure 13.8 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Middle East and Africa (USD Million)
Figure 13.9 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule (USD Million)
Figure 13.10 Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area (USD Million)
Figure 13.11 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material (USD Million)
Figure 13.12 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers (USD Million)
Figure 14.1 Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
Figure 14.2 Pipeline Distribution by Route of Administration
Figure 14.3 FDA Approved Biologics and Biosimilars, Since 2014
Figure 14.4 Approved Prefilled Syringe Combination Products: Cumulative Distribution by Approval Year
Figure 14.5 Clinical Stage Prefilled Syringes Combination Products: Distribution by Phase of Development
Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
Figure 15.5 Prefilled Syringe Developers: Distribution by Year of Establishment
Figure 15.6 Prefilled Syringe Developers: Distribution by Location of Headquarters

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ABB
  • Abbott
  • AbbVie
  • AbbVie Contract Manufacturing
  • Ablynx
  • Accord Healthcare
  • Adamis Pharmaceuticals
  • Adimmune
  • Aguettant
  • AJ Biologics
  • Ajinomoto Bio-Pharma Services
  • Akron Biotech
  • Akums Drugs & Pharmaceuticals
  • Alanza
  • Alcami
  • Alder BioPharmaceuticals
  • Alfasigma
  • Alkermes
  • Alvogen
  • Alvotech
  • Amega Biotech
  • Amgen
  • Amneal Deutschland GmbH
  • AMRI
  • APL
  • Apobiologix
  • Aptar Pharma
  • Aristopharma
  • Asarina Pharma
  • AstraZeneca
  • Austrianova
  • Automated Systems of Tacoma
  • Axcellerate Pharma
  • Bahrain Pharma
  • Baxter
  • Becton Dickinson
  • Berkshire Sterile Manufacturing
  • Bespak
  • Beximco Pharma
  • Bill & Melinda Gates Medical Research Institute
  • Bio Elpida
  • Biocad
  • Biocon
  • BioConnection
  • Biogen
  • Bioinova
  • Biomedical Advanced Research and Development Authority
  • BioPharma Solutions
  • Biotech Vision Care
  • BirgiMefar
  • Boehringer Ingelheim
  • Boehringer Ingelheim BioXcellence
  • Bone Therapeutics
  • Braeburn Pharmaceuticals
  • Bristol-Myers Squibb
  • Bryllan
  • CARBOGEN AMCIS
  • Catalent Biologics
  • Celltrion
  • Cenexi
  • Centrexion Therapeutics
  • Cerium Pharmaceuticals
  • Chugai Pharmaceuticals
  • CinnaGen
  • Ciron Drugs and Pharmaceutical
  • Clover Biopharmaceuticals
  • Coalition for Epidemic Preparedness Innovations
  • Cobra Biologics
  • Coherus Biosciences
  • Combino Pharm
  • Consort Medical
  • Cook Pharmica
  • Corden Pharma
  • Dalton Pharma Services
  • Delpharm
  • DENSO
  • Dhruv Life sciences
  • DM Bio
  • Dynavax Technologies
  • EirGen Pharma
  • Eli Lilly
  • Emcure Pharmaceuticals
  • EMD Serono
  • Emergent BioSolutions
  • Eurofins BioPharma
  • European Medical Contract Manufacturing
  • Ever Pharma
  • Evotec
  • ExCellThera
  • FACET
  • FANUC America
  • Foresee Pharmaceutical
  • Fresenius Kabi
  • Fresenius Kabi Contract Manufacturing
  • Fujifilm
  • Gadea Pharmaceutical Group
  • GC Pharma
  • GeneDesign
  • Genentech
  • Generon (Shanghai)
  • Genmab
  • Genovior Biotech
  • Gerresheimer
  • Gland Pharma
  • GlaxoSmithKline
  • GP Pharm
  • Grand River Aseptic Manufacturing
  • Gulf Biotech
  • Hanmi Pharmaceutical
  • Health Biotech
  • Healthcare Pharmaceuticals
  • Heron Therapeutics
  • Hetero Drugs
  • Hetero Healthcare
  • Hisun Pharmaceuticals USA
  • IDEO
  • IDT Biologika
  • Il-Yang Pharm
  • Injectalia
  • Intas Pharmaceuticals
  • Integrity Bio
  • Ipsen
  • IRISYS
  • Italfarmaco
  • Janssen
  • Johnson & Johnson
  • Kawasaki Heavy Industries
  • Kemwell Biopharma
  • Keryx Biopharmaceuticals
  • Kilitch Healthcare
  • Kiniksa Pharmaceuticals
  • KP Pharmaceutical Technology
  • KUKA
  • Kyowa Hakko Kirin
  • Laboratorios SALVAT
  • Leo Pharma
  • Lifecore Biomedical
  • LSNE Contract Manufacturing
  • Lubrizol Life Science Health
  • Lundbeck
  • Lyell Immunopharma
  • Marchesini Group
  • Massman Automation Designs
  • Medefil
  • Medicago
  • Merck
  • Metrion Biosciences
  • Mithra
  • Mithra Pharmaceuticals
  • Mitsubishi Electric
  • Mitsubishi Gas Chemical
  • Mitsubishi Tanabe Pharma
  • Momenta Pharmaceuticals
  • MorphoSys
  • Mycenax Biotech
  • National Institute of Allergy and Infectious Disease
  • Nemus Bioscience
  • Nipro
  • Northway Biotechpharma
  • Nova Laboratories
  • Novartis
  • Ology Bioservices
  • OmniChem
  • Ompi
  • OMRON Industrial Automation
  • Oncobiologics
  • Oncotec Pharma Produktion
  • "Opiant
  • Pharmaceuticals"
  • Otsuka Pharmaceutical
  • Patheon
  • PCI Pharma Services
  • Pfizer
  • Pfizer CentreOne
  • Pfizer Injectables
  • Pharmaceutics International
  • Pierre Fabre
  • Piramal Enterprises
  • Pisa Farmacéutica
  • Polpharma Biologics
  • Praxis Pharmaceutical
  • Precision Ocular Metrology
  • PrimaPharma
  • PYRAMID Laboratories
  • Recipharm
  • Regeneron
  • Reliance Life Sciences
  • Rentschler Biopharma
  • RHEACELL
  • Roche
  • Rompharm
  • Rovi CM
  • Sabin Vaccine Institute
  • SAFC
  • Samsung Bioepis
  • Samsung Biologics
  • Sandoz
  • Sanofi
  • Saudi Biotech Manufacturing
  • Schott
  • Schott-Kaisha
  • ScinoPharm
  • Seiko Epson
  • Selecta Biosciences
  • Seqirus
  • Sewa Medicals
  • Shandong Pharmaceutical Glass
  • Shandong Weigao
  • Sharp
  • Shire
  • SHL Group
  • Siegfried
  • Singota Solutions
  • SOBI
  • Sovereign Pharma
  • Spectrum Pharmaceuticals
  • Square Pharmaceuticals
  • Staubli
  • Stempeutics
  • Sun Pharma
  • Sunshine Health Products
  • Swissfillon
  • Symphogen
  • Syngene
  • Taisei Kako
  • Taiyo Yakuhin
  • Takeda
  • Tanvex BioPharma
  • Tekpak
  • Terumo
  • Teva Pharmaceutical
  • The United States Department of Health and Human Services (HHS)
  • Tolmar
  • Transcoject
  • TriPharm Services
  • UCB Biopharma
  • Unicep
  • United States Army Medical Materiel Development Activity
  • Universal Robots
  • University of California
  • US Department of Health and Human Services
  • USV
  • Valeant Pharmaceuticals
  • Vanrx Pharmasystems
  • Vaxart
  • VELIT Biopharmaceuticals
  • Vetter Pharma
  • Vitaeris
  • VxP Biologics
  • West Pharmaceuticals
  • Wockhardt
  • Yaskawa Electric
  • YL Biologics
  • Zen Pharma
  • Zhejiang Huahai Pharmaceutical

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of Primary Packaging Container, Company Size, Geographical Regions and Leading Players - Product Image

Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of Primary Packaging Container, Company Size, Geographical Regions and Leading Players

  • Report
  • 340 Pages
  • Global
From
Prefilled Syringes Market Industry Report 2025, by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Barrel Material, Number of Barrel Chamber, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions - Product Image

Prefilled Syringes Market Industry Report 2025, by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Barrel Material, Number of Barrel Chamber, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions

  • Report
  • 867 Pages
  • Global
From
Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial Stoppers (RTU), Cartridge, Cell Therapy Bags), Instruments (Integrated, Automated)), Fill Finish Service, End User - Global Forecast to 2030 - Product Image

Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial Stoppers (RTU), Cartridge, Cell Therapy Bags), Instruments (Integrated, Automated)), Fill Finish Service, End User - Global Forecast to 2030

  • Report
  • 466 Pages
  • Global
From
Prefilled Syringe Packaging Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Prefilled Syringe Packaging Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Disposable Prefilled Syringes Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Image

Disposable Prefilled Syringes Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.